Assessment of the sofosbuvir + daclatasvir (±) ribavirin treatment and the prognostic efficacy of interferon-gamma induced protein 10, macrophage inflammatory-1-beta, and C-reactive protein in Hepatitis C Egyptian patients' therapy outcome

Assessment of the sofosbuvir + daclatasvir (±) ribavirin treatment and the prognostic efficacy of interferon-gamma induced protein 10, macrophage inflammatory-1-beta, and C-reactive protein in Hepatitis C Egyptian patients' therapy outcome

Background: Hepatitis C virus (HCV) is the most important virus among the infectious agents as the cause of liver disease in Egypt. The aim of this work was to assess the efficacy and tolerability of the sofosbuvir + daclatasvir (±) ribavirin (SOF + DCV [±] RBV) regimens and to evaluate the associat...

Full description

Bibliographic Details
Main Authors: Hany Mohammed Ibrahim, Faten Roshdy Abdel-Ghaffar, Ahmed Bahgat Zied, Sameha Husni El-Ghareeb
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Biomedical and Biotechnology Research Journal
Subjects:
c-reactive protein
daclatasvir
egypt
induced protein 10
macrophage inflammatory-1-beta
ribavirin
sofosbuvir
Online Access:http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=109;epage=116;aulast=Ibrahim

Internet

http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=109;epage=116;aulast=Ibrahim

Similar Items